Standard and competing risk analysis of the effect of albuminuria on cardiovascular and cancer mortality in patients with type 2 diabetes mellitus

Table 1 Baseline characteristics of the study cohort, stratified by albuminuria status. Data represent means ± SD unless a percentage (%) is stated

Baseline variable	Everyone (n = 54,801)	Normoalbuminuria (n = 42,662)	Albuminuria (n = 12,139)	p value*
Men, n (%)	30,164 (55.0%)	23,611 (55.3%)	6553 (54.0%)	0.081
Age (years)	67.4 ± 11.9	66.8 ± 11.8	69.4 ± 12.2	< 0.001
BMI (kg/m²)	29.7 ± 5.9	29.7 ± 5.9	29.8 ± 6.2	0.135
SBP (mmHg)	138.4 ± 16.9	137.7 ± 16.4	140.8 ± 18.4	< 0.001
Total: HDL cholesterol ratio	3.8 ± 1.2	3.8 ± 1.2	3.8 ± 1.2	0.423
HbA_1c (mmol/mol)	56.9 ± 15.3	56.1 ± 14.7	59.6 ± 17.0	< 0.001
Never smoked, n (%)	13,308 (24.3%)	10,499 (24.6%)	2809 (23.1%)	< 0.001
Ex-smokers, n (%)	28,755 (52.5%)	22,604 (53.0%)	6151 (50.7%)
Current smokers, n (%)	12,738 (23.2%)	9559 (22.4%)	3179 (26.2%)

ISSN: 2397-7523